MedPath

Treatment of Periodontal bony defect using various bone graft

Not yet recruiting
Conditions
Chronic periodontitis,
systemically healthy individuals diagnosed with periodontal osseous intrabony defect on clinical and radiographic evaluation with Probing Depth more than 4 mm and an intrabony component more than 3 mm
Registration Number
CTRI/2023/09/057332
Lead Sponsor
Sardar Patel Post Graduate of Dental and Medical Sciences
Brief Summary

Periodontitis is an inflammatory disease of the periodontium which elicits an immune response resulting in the loss of supporting structures of the teeth. The bone loss which is induced by periodontitis i.e. osseous defects occur either single or in different combination forms. Intrabony osseous defect is defined as a “periodontal defect within the bone surrounded by one, two or three bony walls or a combinationâ€. Treatment with grafting modalities, xenogenic or alloplastic osteoconductive materials, such as bovine bone-derived mineral, coralline calcium carbonate, calcium-layered composite of poly-methyl-methacrylate and poly-hydroxyl-ethyl-methacrylate, hydroxyapatite, bioactive glass and tricalcium phosphate are options. Bone graft is use to fill the defect, supporting and promoting new bone formation, through its use as mechanical scaffold and provides a structure for new cells to form new bone growth in the healing process. Hydroxyapatite cement (HAC) has been extensively studied as the bone grafting material in periodontal regeneration. The biocompatibility, osteoconductive nature and resorptive properties of HAC suggest it has potential to function as a successful bone substitute material. biocomposites(BC) such as beta tricalcium phosphate and calcium sulfate represent a unique bi-phasic composition with a negative charged surface. This property stimulates bone cell activity by harnessing key proteins, osteoblast adhesion and proliferation.In this study thirty patients diagnosed with periodontitis showing pocket depth >5mm and radiographic evidence of vertical/ angular bony defects will be selected from Department of Periodontology, SPPGIDMS, Lucknow and will be allocated randomly into two groups. Groups A (biocomposites + open flap debridement) and Group B (hydroxyapatite cement + open flap debridement). Clinical periodontal parameters like probing pocket depths (PPD), clinical attachment level (CAL), plaque index (PI), gingival index (GI), and radiographic assessment of the defect will be evaluated at baseline, 3 and 6 months after treatment.The present study will evaluate and compare the efficacy of injectable biocomposites and HAC in periodontal regeneration. We anticipate that this will enable improved treatment of periodontal osseous defects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1.Patient age between16-40 years diagnosed with periodontitis 2.Teeth selection All the teeth diagnosed with periodontal osseous intrabony defect Two or three wall defect on clinical and radiographic evaluation 3.PD more than or equal to 4 mm and an intrabony component more than or equal to 3 mm 4.The depth of the intraosseous component of the defect was evaluated clinically and radiographically during the screening phase but it had to be confirmed during surgery 5.Systemically healthy patients 6.Patients with established willingness and ability to perform adequate oral hygiene.

Exclusion Criteria
  • Heavy smoking (more than 10 cigarettes) 2.
  • Presence of underlying medical conditions such as immunosuppression or diabetes pregnancy and medically compromised conditions that would put the patient at risk for periodontal surgery.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The outcome expected will be to compare theBaseline | 3 months | 6 months
regenerative capacity of injectable biocomposites & granular form of Hydroxyapatites inBaseline | 3 months | 6 months
an adjunct with OFD in treatment of intrabony defects.Baseline | 3 months | 6 months
Secondary Outcome Measures
NameTimeMethod
the secondary outcome is radiographic evaluation of the bone fill & bone density post operative in treatments of intrabony defects.6 months post operative

Trial Locations

Locations (1)

SARDAR PATEL POST GRADUATE INSTITUTE OF DENTAL AND MEDICAL SCIENCES

🇮🇳

Lucknow, UTTAR PRADESH, India

SARDAR PATEL POST GRADUATE INSTITUTE OF DENTAL AND MEDICAL SCIENCES
🇮🇳Lucknow, UTTAR PRADESH, India
DR HIMANI TRIPATHI
Principal investigator
9792320403
tripathihimani260@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.